Prokaryotic and eukaryotic cell-free systems for prototyping (CRADA Final Report)
CRADA FP00008491 between Berkeley Lab and Synvitrobio, Inc. (now Tierra Biosciences) validated the use of cell-free phenotyping to conduct functional genomics. Currently, most phenotyping work occurs using cellular fermentation methods and cellular techniques. This limits functional genomics throughput, which increasingly cannot handle the wealth of genetic information developed from next-generation sequencing technologies. De-risking a cell-free phenotyping approach has the advantage of increasing multiple-fold the throughput of genetic information that can be explored and expanding the $3B market for protein synthesis and characterization, leading to the accelerated development of human therapeutics and new biologically based materials.
59 BASIC BIOLOGICAL SCIENCES↗